Nonconventional genetic risk factors for cardiovascular disease

Current Atherosclerosis Reports

Volumn 8, Issue 3, 2006, Pages 184-192

  Tymchuk, Christopher N ^b   Hartiala, Jaana ^b   Patel, Pragna I ^b   Mehrabian, Margarete ^b   Allayee, Hooman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CONNEXIN 37; GALECTIN 2; HIGH DENSITY LIPOPROTEIN; LEUKOTRIENE A4 HYDROLASE; LYMPHOTOXIN; MATRIX METALLOPROTEINASE; MYOCYTE ENHANCER FACTOR 2; PHOSPHODIESTERASE IV; THROMBOSPONDIN; TOLL LIKE RECEPTOR 4;

ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CHROMOSOME 10Q; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 1P; CHROMOSOME 2Q; CHROMOSOME 5Q; CHROMOSOME 6P; CORONARY ARTERY DISEASE; FAMILY STUDY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; NONHUMAN; REVIEW; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MODELS, BIOLOGICAL; MODELS, GENETIC; RISK FACTORS;

EID: 33646386931     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-006-0072-2     Document Type: Review

References (50)

1. Lusis AJ: Atherosclerosis. Nature 2000, 407:233-241.
2. Lusis AJ, Weinreb A, Drake TA, Allayee H: Genetics of Atherosclerosis. In Textbook of Cardiovascular Disease. Edited by Topol EJ. Philadelphia: Lippincott-Raven; 2002: Chapter 98.
3. Wang Q, Rao S, Shen GQ, et al.: Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 2004, 74:262-271.
4. Yamada Y, Izawa H, Ichihara S, et al.: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
5. Hauser ER, Crossman DC, Granger CB, et al.: A genome-wide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 2004, 75:436-447.
6. Wang L, Fan C, Topol SE, et al.: Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003, 302:1578-1581.
7. Bhagavatula MR, Fan C, Shen GQ, et al.: Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 2004, 13:3181-3188.
8. Weng L, Kavaslar N, Ustaszewska A, et al.: Lack of MEF2A mutations in coronary artery disease. J Clin Invest 2005, 115:1016-1020.
9. Fox CS, Cupples LA, Chazaro I, et al.: Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet 2004, 74:253-261.
10. Wang D, Yang H, Quinones MJ, et al.: A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke 2005, 36:540-545.
11. Lange LA, Lange EM, Bielak LF, et al.: Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 2002, 22:418-423.
12. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, et al.: Localization of a susceptibility gene for common forms of stroke to 5q12. Am J Hum Genet 2002, 70:593-603.
13. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al.: The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003, 35:131-138.
14. Ozaki K, Ohnishi Y, Iida A, et al.: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002, 32:650-654.
15. Iwanaga Y, Ono K, Takagi S, et al.: Association analysis between polymorphisms of the lymphotoxin-alpha gene and myocardial infarction in a Japanese population. Atherosclerosis 2004, 172:197-198.
16. Laxton R, Pearce E, Kyriakou T, Ye S: Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Genes Immunol 2005, 6:539-541.
17. Szolnoki Z, Havasi V, Talian G, et al.: Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke. J Mol Neurosci 2005, 27:205-211.
18. Yamada A, Ichihara S, Murase Y, et al.: Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 2004, 82:477-483.
19. Ozaki K, Inoue K, Sato H, et al.: Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004, 429:72-75.
20. Kiechl S, Lorenz E, Reindl M, et al.: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192.
21. Ameziane N, Beillat T, Verpillat P, et al.: Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003, 23:e61-e64.
22. Holloway JW, Yang IA, Ye S: Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet Genom 2005, 15:15-21.
23. Balistreri CR, Candore G, Colonna-Romano G, et al.: Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004, 292:2339-2340.
24. Topol EJ, McCarthy J, Gabriel S, et al.: Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001, 104:2641-2644.
25. McCarthy JJ, Parker A, Salem R, et al.: Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004, 41:334-341.
26. Wessel J, Topol EJ, Ji M, et al.: Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. Am Heart J 2004, 147:905-909.
27. Yamada Y, Ichihara S, Izawa H, et al.: Genetic risk for coronary artery disease in individuals with or without type 2 diabetes. Mol Genet Metab 2004, 81:282-290.
28. Listi F, Candore G, Lio D, et al.: Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 2005, 102:269-271.
29. Newby AC, Johnson JL: Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability. Circ Res 2005, 97:958-960.
30. Pollanen PJ, Lehtimaki T, Mikkelsson J, et al.: Matrix metalloproteinase3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 2005, 180:73-78.
31. Pearce E, Tregouet DA, Samnegard A, et al.: Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005, 97:1070-1076.
32. Shiffman D, Ellis SG, Rowland CM, et al.: Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 2005, 77:596-605.
33. Ohashi R, Mu H, Yao Q, Chen C: Cellular and molecular mechanisms of atherosclerosis with mouse models. Trends Cardiovasc Med 2004, 14:187-190.
34. Allayee H, Ghazalpour A, Lusis AJ: Using mice to dissect genetic factors in atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:1501-1509.
35. Wang X, Ishimori N, Korstanje R, et al.: Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 2005, 77:1-15.
36. Mehrabian M, Allayee H: 5-lipoxygenase and atherosclerosis. Curr Opin Lipidol 2003, 14:447-457.
37. Mehrabian M, Allayee H, Wong J, et al.: Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002, 91:120-126.
38. Zhao L, Moos MP, Grabner R, et al.: The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 2004, 10:966-973.
39. Mehrabian M, Allayee H, Stockton J, et al.: Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet 2005, 37:1224-1233.
40. Aiello RJ, Bourassa PA, Lindsey S, et al.: Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 2002, 22:443-449.
41. Subbarao K, Jala VR, Mathis S, et al.: Role of leukotriene B4 leceptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol 2004, 24:369-375.
42. Dwyer JH, Allayee H, Dwyer KM, et al.: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004, 350:29-37.
43. Helgadottir A, Manolescu A, Thorleifsson G, et al.: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36:233-239.
44. Lohmussaar E, Gschwendtner A, Mueller JC, et al.: ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005, 36:731-736.
45. Helgadottir A, Gretarsdottir S, St Clair D, et al.: Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005, 76:505-509.
46. Helgadottir A, Manolescu A, Helgason A, et al.: A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2005, In press.
47. Hakonarson H, Thorvaldsson S, Helgadottir A, et al.: Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA 2005, 293:2245-2256.
48. Pajukanta P, Cargill M, Viitanen L, et al.: Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000, 67:1481-1493.
49. Broeckel U, Hengstenberg C, Mayer B, et al.: A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002, 30:210-214.
50. Harrap SB, Zammit KS, Wong ZY, et al.: Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 2002, 22:874-878.